Caricamento...
K13 mutations and pfmdr1 copy number variation in Plasmodium falciparum malaria in Myanmar
BACKGROUND: Artemisinin-based combination therapy has been first-line treatment for falciparum malaria in Myanmar since 2005. The wide extent of artemisinin resistance in the Greater Mekong sub-region and the presence of mefloquine resistance at the Myanmar-Thailand border raise concerns over resist...
Salvato in:
| Pubblicato in: | Malar J |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4765153/ https://ncbi.nlm.nih.gov/pubmed/26911145 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12936-016-1147-3 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|